Commercial Due Diligence on a Next Generation Medical Training Tool

Commercial Due Diligence on a Next Generation Medical Training Tool

Christine O'Connell • March 18, 2021
Christine O'Connell • March 18, 2021

Share

Client and project overview

  • Conducted commercial due diligence (CDD) for a leading B2B data and information business.
  • Focused on evaluating the commercial attractiveness of the 3DDA solution market. We also validated the investment thesis – that the target would be a strategic extension for our client’s medical book assets because it capitalized on the growing adoption of digital and virtual reality technologies


Key questions

As part of our CDD process, we focused on the following questions:

  • What was the sub-segment size and notional opportunity for 3DDA tools?
  • Who are the addressable users?
  • What is the range of content and related tools used by students and medical /nursing schools for foundational and advanced anatomy courses?
  • To what extent do current solutions address customer needs?
  • What were the relative strengths and weaknesses of the target and competitors’ capabilities and products across the identified use cases/feature set?
  • What were the synergies between our client the target business?


Methodology highlights

  • Conducted targeted interviews with market experts, current and prospective customers of the target company, competitors’ B2B customers, our client’s B2B customers, and competing vendors
  • Sized the relevant sub-segment using both supply and demand-side methodology
  • Re-built the business plan for both B2B and B2C customers within a tight timeframe with limited access to target management/customer data


Results

Based on our insights, our client acquired the company successfully two months after we delivered the project.

Read More

Stax Sell-side Support: Equity Methods on its Acquistion by HGGC​
April 29, 2025
Stax supported Equity Methods, provider of executive & stock-based compensation reporting, valuation, and advisory services, on its recent acquisition by HGGC. Read more.
Stax Named a 2025 Top Consulting Firm by Management Consulted
April 25, 2025
Stax is honored to be recognized once again as a Top Consulting Firm by Management Consulted. Click learn more about the criteria behind the award and how Stax continues to grow.
Featured by StacheCow: Private Equity Insider: What We Look for in a Brand — Paul Edwards, Stax
April 25, 2025
Paul Edwards was approached by StacheCow to discuss the top traits PE firms look for in a brand, the importance of leadership, and how to prepare for a stronger, smoother exit. Read more.
Featured by Modern Healthcare: Why economic uncertainty is slowing digital health M&A
April 25, 2025
Brad Kuntz was featured in Modern Healthcare's recent article, where he discussed potential acquirers need for economic clarity and the extent of tariff impacts. Click here to read more.
Featured by MicroGrid: How President Trump’s China Tariffs Could Undermine Distributed Energy Gains
April 23, 2025
Phil Dunne was featured by MicroGrid to share his thoughts on the Trump administration's tariffs on China and how they could impact the US energy and EV markets. Read the full feature here.
Stax Recognized by Consulting Magazine for Mentorship and Enrichment Program
April 22, 2025
Stax was recently honored by Consulting Magazine at the Rising Star Awards in Chicago for its innovative approach to talent development. Read about the award ceremony here.
Show More